INTERPARFUMS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data INTERPARFUMS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	521	591	676	714	539	880	1,087	1,318	1,452	1,489
Cost of revenue	195	215	248	268	208	323	392	479	525	541
Gross profit	326	376	428	446	331	557	694	839	927	947
Selling, general and administrative	259	296	333	341	261	406	492	588	649	677
Operating income	66.7	78.6	94.7	105	70.1	148	194	251	275	270
Interest expense	2.34	1.99	2.58	2.15	1.97	2.83	3.6	11.3	7.83	7.25
Interest income	3.33	2.98	3.96	3.69	2.87	3.4	5.49	10.7	2.22
Other non-operating income	0.4	-0.56	1.13	0.42	-0.73	2.97	-0.08	-1.79	-6.41	1.02
Pre-tax income	67.1	78.1	95.9	105	69.3	151	194	250	268	271
Income tax	23.8	22.8	26.1	29.1	19.4	41	43.2	61.8	65	63.2
Net income to minority interests	9.92	13.7	15.9	15.8	11.7	22.6	30.1	35.1	39.1	39.8
Net income	33.3	41.6	53.8	60.2	38.2	87.4	121	153	164	168
EBITDA	70.4	82.4	98.8	108	79.2	161	217	269	303	296
EPS, basic	1.07	1.33	1.72	1.92	1.21	2.76	3.80	4.77	5.13	5.25
EPS, diluted	1.07	1.33	1.71	1.90	1.21	2.75	3.78	4.75	5.12	5.24
Shares, basic (weighted)	31.1	31.2	31,308	31.5	31.5	31.7	31.9	32	32	32.1
Shares, diluted (weighted)	31.2	31.3	31,522	31.7	31.7	31.8	32	32.1	32.1	32.1
Dividend per share	0.62	0.72	0.91	1.16	0.33	1.00	2.00	2.50	3.00	3.20

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	162	208	193	133	170	159,613	105
Short-term investments	94.2	69.9	67.9	120	127	160	151	94.3	109	137
Receivables	105	121	133	133	124	159	198	247	275	321
Inventory	97	137	162	168	159	199	290	372	372	351
Other current assets	6.24	7.36	12.6	17.1	16.9	21.4	15.7	29.5	38.6	40
Total current assets	472	549	572	573	601	710	788	839	926	1,027
Property, plant and equipment	10.1	10.3	9.84	11.1	19.6	149	167	169	154	185
Lease right-of-use assets				28.4	24.7	33.7	28	28.6	24.6	23.3
Intangible assets	184	200	204	202	214	214	291	296	282	325
Other non-current assets	8.25	8.01	6.3	6.08	23	30.6	24.1	21.6	18.5	20.2
Total assets	682	778	798	829	890	1,145	1,309	1,369	1,411	1,585
Accounts payable	49.5	52.6	58.3	54.1	35.6	82	88.4	97.4	91	77.2
Accrued liabilities	62.6	81.8	94.7	96.4	95.6	137	214	179	173	190
Short-term debt	21.5	24.4	23.2	12.3	14.6	15.9	28.5	29.6	41.6	54.8
Total current liabilities	142	167	189	184	156	245	345	325	332	344
Long-term debt	53.1	36.2	22.9	10.7	10.1	133	151	128	116	121
Lease liabilities				24.6	21.4	29.2	24.3	24.5	20.5	16
Total liabilities	199	207	212	220	188	407	520	477	469	481
Total debt	74.6	60.6	46.1	23.1	24.7	149	180	157	157	176
Paid-in capital	63.1	66	70	70.7	75.7	87.1	90.2	98.6	107	128
Retained earnings	403	423	449	475	504	561	620	694	763	829
Treasury stock	-37.5	-37.5	-37.5	-37.5	-37.5	-37.5	-37.5	-52.9	-52.9	-66.7
Other comprehensive income	-58	-17.8	-33.7	-39.9	-6	-38.4	-56.1	-40.2	-72.2	-9.03
Shareholders' equity	370	433	448	468	536	572	617	699	745	881
Minority interests	113	137	138	141	167	166	171	193	198	223
Total equity	484	571	586	609	702	738	788	892	943	1,104
Total liabilities and equity	682	778	798	829	890	1,145	1,309	1,369	1,411	1,585
Shares outstanding	31.1	31.2	31.4	31.5	31.6	31.8	32	32	32.1	32.1

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	43.2	55.3	69.7	76.1	50	110	151	188	203	208
Depreciation and amortization	3.7	3.8	4.1	3.7	9.07	12.7	22.5	17.3	28.4	25.3
Stock-based compensation	1.2	2.09	2.21	3.39	3.03	2.85	3.14	2.53	2.38	1.57
Deferred income tax	-1.37	-0.59	-0.16	-2.33	0.58	-0.47	-3.6	-1.71	-2.08	1.67
Change in receivables	-13.2	4.12	-21.5	1.12	13.2	-45.4	-59.6	-36.8	-41.3	-22.1
Change in inventory	-0.91	28.5	-29.3	-5.93	19.3	-49.8	-98.3	-73.7	-17.2	55.2
Change in payables	18.7	5.7	25.6	-4.96	-32.2	103	64.7	3.06	4.87	-32
Cash from operations	54.6	35.9	63	76.5	65	120	73	106	188	215
Capital expenditures	-4.78	-3.02	-3.96	-5.43	-11	-141	-33.8	-6.47	-4.74	-24.4
Purchases of investments	-57.3	-31.9	-10	-98	-7.58	-55.7	-1.04	-221	-206	-162
Sales and maturities of investments					11.5	10.6	0.9	282
Cash from investing	-20.4	36.9	-13.6	-64.6	-22.3	-188	-90.6	7.26	-44.8	-61.1
Debt issued	0				13.4	157	52.5	0	43.3	56.5
Debt repaid	-21.9	-22.4	-23.5	-22.3	-13.7	-43.1	-19.9	-28.8	-34.7	-50.3
Stock issued	1.58	1.96	3.41	4.46	2.77	5.39	6	8.03	7.05	7.58
Share buybacks	-0.08						0	-15.4	0	-13.9
Dividends paid	-18	-21.2	-26.3	-34.6	-20.8	-31.7	-63.7	-80	-96	-103
Cash from financing	-44.6	-47.6	-55.9	-68.2	-18.6	78.2	-45.6	-133	-101	-131
Exchange rate effect					12.2	-11.2	-0.49	3.93	-5.07	10.2
Net change in cash	-15.1	46.5	-15.2	-59.7	36.3	-1.29	-63.7	-16.3	37	32.7
Free cash flow	49.8	32.9	59.1	71	54	-21.7	39.3	99.3	183	190
Interest paid	2.24	1.81	1.75	1.76	1.11	2.47	2.99	5.82	7.5	6.69
Income taxes paid	28.1	24.3	25	26.3	21.8	40.5	38.5	61	63.2	77.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $117.93 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	63.8%	Gross profit / revenue.
Operating margin	17.3%	Operating income / revenue.
EBITDA margin	18.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	17.8%	Pre-tax income / revenue.
Net margin	11.2%	Net income / revenue.
FCF margin	16.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	17.1%	Cash from operations / revenue.
Effective tax rate	23.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	19.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.3%	Net income / average total assets.
Return on invested capital (ROIC)	19.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	46.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.7%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	2.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	11.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	22.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	2.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	10.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	23.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-1.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	11.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	31.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-2.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	10.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	30.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	2.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	11.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	34.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	2.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	11.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	34.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	14.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	43.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	27.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	4.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	69.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	28.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	6.7%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	17.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	57.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	18.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	12.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	10.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	12.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	6.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	12.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.31x	Current assets / current liabilities.
Debt / equity	0.16x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	9.6%	Total debt / total assets.
Liabilities / assets	26.8%	Total liabilities / total assets.
Interest coverage	38.1x	Operating income / interest expense.
Working capital	$663.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	20.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$558.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.01x	Revenue / average total assets.
Fixed asset turnover	8.52x	Revenue / average property, plant and equipment.
Inventory turnover	1.45x	Cost of revenue / average inventory.
Days inventory	252 days	365 x average inventory / cost of revenue.
Receivables turnover	4.98x	Revenue / average receivables.
Days sales outstanding	73 days	365 x average receivables / revenue.
Days payables	56 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	270 days	Days inventory + days sales outstanding - days payables.
FCF conversion	146.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	4.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.24	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$46.89	Revenue / diluted weighted shares.
FCF per share	$7.68	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.00	Cash from operations / diluted weighted shares.
Book value per share	$27.18	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$17.44	Tangible book value / shares outstanding.
Payout ratio	61.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	41.7%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	6.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$3.78B	Share price x shares outstanding.
Enterprise value	$3.88B	Market cap + total debt - cash - short-term investments.
P/E	22.5x	Market cap / net income. Only when net income is positive.
P/S	2.52x	Market cap / revenue.
P/B	4.34x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	6.76x	Market cap / tangible book value, when positive.
P/FCF	15.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	14.7x	Market cap / cash from operations, when positive.
EV/Sales	2.58x	Enterprise value / revenue.
EV/EBIT	15.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.7x	Enterprise value / EBITDA, when both are positive.
EV/FCF	15.8x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.5%	Free cash flow / market cap.
Earnings yield	4.4%	Net income / market cap (the inverse of P/E).
Dividend yield	2.7%	Dividends paid over the period / market cap.
Shareholder yield	3.1%	(Dividends paid + share buybacks) / market cap.
PEG	1.96x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was INTERPARFUMS INC's revenue in fiscal 2025?

INTERPARFUMS INC reported revenue of $1.49B for fiscal 2025, 2.5% higher than the year before.

Was INTERPARFUMS INC profitable in fiscal 2025?

Yes. Net income was $168.4M, a net margin of 11.3%.

How much free cash flow did INTERPARFUMS INC generate in fiscal 2025?

Cash from operations of $214.9M minus capital expenditures of $24.4M left free cash flow of $190.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to INTERPARFUMS INC